WO2008010008A3 - Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine - Google Patents
Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine Download PDFInfo
- Publication number
- WO2008010008A3 WO2008010008A3 PCT/IB2006/002252 IB2006002252W WO2008010008A3 WO 2008010008 A3 WO2008010008 A3 WO 2008010008A3 IB 2006002252 W IB2006002252 W IB 2006002252W WO 2008010008 A3 WO2008010008 A3 WO 2008010008A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cardiovascular
- rennin
- combinations
- inhibitors
- angiotensin inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne de nouvelles compositions pharmaceutiques, leur procédé de préparation et l'utilisation de ces compositions, lesquelles sont administrées comme polythérapie pour le traitement d'affections cardiovasculaires et de troubles associés, notamment sous la forme d'une combinaison d'antagonistes de l'angiotensine II, de régulateurs lipidiques (inhibiteurs de HMG-CoA réductase), d'inhibiteurs de l'agrégation plaquettaire et de diurétiques.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2006/002252 WO2008010008A2 (fr) | 2006-07-17 | 2006-07-17 | Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2006/002252 WO2008010008A2 (fr) | 2006-07-17 | 2006-07-17 | Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008010008A2 WO2008010008A2 (fr) | 2008-01-24 |
WO2008010008A3 true WO2008010008A3 (fr) | 2009-04-16 |
Family
ID=38957139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/002252 WO2008010008A2 (fr) | 2006-07-17 | 2006-07-17 | Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008010008A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2453307C2 (ru) * | 2006-10-30 | 2012-06-20 | Ханол Биофарма Ко.Лтд | Комплексная фармацевтическая композиция с контролируемым высвобождением, содержащая блокаторы рецепторов ангиотензина-ii и ингибиторы гидроксиметилглутарил-кофермент а-редуктазы |
KR100955669B1 (ko) * | 2007-08-13 | 2010-05-06 | 한올바이오파마주식회사 | HMGCoA 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법 |
KR101248804B1 (ko) * | 2010-05-14 | 2013-03-29 | 한미사이언스 주식회사 | HMG-CoA 환원효소 억제제 및 이베살탄을 포함하는 이층정 약제학적 복합제제 |
BR102012020648A2 (pt) * | 2012-08-17 | 2014-12-09 | Hypermarcas S A | Preparação farmacêutica oral sólida para a prevenção de doença cardio e cerebrovasculares e comprimido |
KR20140030505A (ko) * | 2012-08-31 | 2014-03-12 | 한미약품 주식회사 | 이베살탄 및 HMG-CoA 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제 |
CN105232484A (zh) * | 2015-09-24 | 2016-01-13 | 青岛华之草医药科技有限公司 | 一种解热、镇痛、抗炎药物阿司匹林组合物片剂 |
EP3342400A1 (fr) * | 2016-12-31 | 2018-07-04 | Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. | Composition pharmaceutique comprenant de la valsartane et du chlorthalidone |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040259925A1 (en) * | 2003-01-16 | 2004-12-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
US20050080071A1 (en) * | 2001-01-26 | 2005-04-14 | Davis Harry R. | Treatment methods |
US20050085511A1 (en) * | 2003-10-08 | 2005-04-21 | Qiao Jennifer X. | Cyclic diamines and derivatives as factor Xa inhibitors |
US20050209288A1 (en) * | 2004-01-12 | 2005-09-22 | Grogan Donna R | Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use |
-
2006
- 2006-07-17 WO PCT/IB2006/002252 patent/WO2008010008A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050080071A1 (en) * | 2001-01-26 | 2005-04-14 | Davis Harry R. | Treatment methods |
US20040259925A1 (en) * | 2003-01-16 | 2004-12-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
US20050085511A1 (en) * | 2003-10-08 | 2005-04-21 | Qiao Jennifer X. | Cyclic diamines and derivatives as factor Xa inhibitors |
US20050209288A1 (en) * | 2004-01-12 | 2005-09-22 | Grogan Donna R | Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use |
Also Published As
Publication number | Publication date |
---|---|
WO2008010008A2 (fr) | 2008-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010003127A3 (fr) | Antagonistes des récepteurs de la prostaglandine d<sb>2</sb> | |
WO2010127099A3 (fr) | Compositions pharmaceutiques comprenant de l'epa et un agent cardiovasculaire et leurs procédés d'utilisation | |
WO2010037059A3 (fr) | Antagonistes hétéroaryliques des récepteurs de prostaglandine d<sb>2</sb> | |
WO2009108720A3 (fr) | Antagonistes des récepteurs d2 de la prostaglandine | |
WO2010057118A3 (fr) | Antagonistes hétérocycliques des récepteurs de la prostaglandine d2 | |
WO2009145989A3 (fr) | Antagonistes d’aminoalkylphényle de récepteurs de prostaglandine d<sb>2</sb> | |
WO2010039977A3 (fr) | Antagonistes d'hétéroaryle des récepteurs de la prostaglandine d2 | |
WO2010054113A3 (fr) | Antagonistes de cycloalkane[b]azaindole de récepteurs de la prostaglandine d2 | |
WO2007127505A3 (fr) | Composés chimiques | |
WO2008148074A3 (fr) | Inhibiteurs de mtor et methodes de traitement mettant en œuvre ces inhibiteurs | |
WO2011141685A3 (fr) | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants | |
WO2010042652A3 (fr) | Antagonistes hétéroalkyl biphényle des récepteurs de la prostaglandine d2 | |
WO2012080727A3 (fr) | Inhibiteurs de caséine kinase 1 delta (ck1delta) | |
WO2010008864A3 (fr) | Antagonistes de cycloalcane[b]indole de récepteurs de prostaglandine d2 | |
WO2008010222A3 (fr) | Conjugués innovants, compositions pharmaceutiques les comprenant et leurs utilisations | |
WO2006010423A3 (fr) | Nouveaux composes d'azaindole inhibiteurs de mtp et d'apob | |
WO2007038459A3 (fr) | Composes de carboxyamine et leurs methodes d'utilisation | |
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
WO2008115974A3 (fr) | Analogues de pyrazolopyrimidine et leur utilisation en tant qu'inhibiteurs de kinase mtor et kinase pi3 | |
MY144857A (en) | Phamaceutical composition comprising amlodipine and losartan | |
WO2009121039A3 (fr) | Administration de compositions de benzodiazépine | |
WO2008010008A3 (fr) | Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine | |
WO2010085820A3 (fr) | Composés tricycliques en tant qu'antagonistes des récepteurs d2 de la prostaglandine | |
WO2011150201A3 (fr) | Composés azolylamide et leurs procédés d'utilisation | |
WO2008073350A3 (fr) | Dérivés d'acétylène et leur utilisation pour lier et imager des plaques amyloïdes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06795278 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06795278 Country of ref document: EP Kind code of ref document: A2 |